CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Open-market buy Director bought 2,407 shares at an average $2.30 ($5,531)
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 214 shares at an average $2.61 ($559)
- 4 Open-market buy Director bought 318 shares at an average $2.61 ($830)
- 4 Open-market buy Director bought 641 shares at an average $2.61 ($1,673)
- 4 Open-market buy Director bought 1,069 shares at an average $2.61 ($2,791)
- 8-K Event Shareholder vote results
- 4 Other disposition Sr VP/Chief Commercial Officer disposed of 15,000 shares (other)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Shares withheld for taxes VP and Chief Compliance Office gave up 1,280 shares (to pay taxes)
- 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Shares withheld for taxes Chairman and CEO gave up 37,205 shares (to pay taxes)
- 8-K Event Other events
Page 15 of 52 · 1,039 filings